↓ Skip to main content

Cochrane Database of Systematic Reviews

Pygeum africanum for benign prostatic hyperplasia

Overview of attention for article published in Cochrane database of systematic reviews, January 1998
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Citations

dimensions_citation
107 Dimensions

Readers on

mendeley
134 Mendeley
Title
Pygeum africanum for benign prostatic hyperplasia
Published in
Cochrane database of systematic reviews, January 1998
DOI 10.1002/14651858.cd001044
Pubmed ID
Authors

T Wilt, A Ishani, R Mac Donald, I Rutks, G Stark

Abstract

Benign prostatic hyperplasia (BPH), nonmalignant enlargement of the prostate, can lead to obstructive and irritative lower urinary tract symptoms (LUTS). The pharmacologic use of plants and herbs (phytotherapy) for the treatment of LUTS associated with BPH has been growing steadily. The extract of the African prune tree, Pygeum africanum, is one of the several phytotherapeutic agents available for the treatment of BPH.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 <1%
Australia 1 <1%
Unknown 132 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 15%
Researcher 19 14%
Student > Bachelor 19 14%
Other 11 8%
Professor > Associate Professor 8 6%
Other 24 18%
Unknown 33 25%
Readers by discipline Count As %
Medicine and Dentistry 47 35%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Nursing and Health Professions 8 6%
Agricultural and Biological Sciences 7 5%
Biochemistry, Genetics and Molecular Biology 5 4%
Other 19 14%
Unknown 38 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 60. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 December 2023.
All research outputs
#702,164
of 25,381,151 outputs
Outputs from Cochrane database of systematic reviews
#1,317
of 12,596 outputs
Outputs of similar age
#433
of 93,698 outputs
Outputs of similar age from Cochrane database of systematic reviews
#1
of 5 outputs
Altmetric has tracked 25,381,151 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,596 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,698 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them